These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH. Poling JS, Yonescu R, Subhawong AP, Sharma R, Argani P, Ning Y, Cimino-Mathews A. Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281 [Abstract] [Full Text] [Related]
26. Cytopathologic analysis of stroma-poor salivary gland epithelial/myoepithelial neoplasms on fine needle aspiration. Chen L, Ray N, He H, Hoschar A. Acta Cytol; 2012 Jul; 56(1):25-33. PubMed ID: 22236742 [Abstract] [Full Text] [Related]
27. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts. Togashi Y, Dobashi A, Sakata S, Sato Y, Baba S, Seto A, Mitani H, Kawabata K, Takeuchi K. Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490 [Abstract] [Full Text] [Related]
29. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma. Tadi S, Cheung VK, Lee CS, Nguyen K, Luk PP, Low TH, Palme C, Clark J, Gupta R. Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331 [Abstract] [Full Text] [Related]
38. Distinguishing adenoid cystic carcinoma from cylindromatous adenomas in salivary fine-needle aspirates: the cytologic clues and their ultrastructural basis. Yang GC, Waisman J. Diagn Cytopathol; 2006 Apr; 34(4):284-8. PubMed ID: 16544336 [Abstract] [Full Text] [Related]